|
Title
|
|
|
|
Diarylquinolines, synthesis pathways and quantitative structure-activity relationship studies leading to the discovery of TMC207
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| The emergence of multidrug-resistant strains of Mycobacterium tuberculosis and resistance to current anti-TB drugs call for the discovery and development of new effective anti-TB drugs. TMC207 is the lead candidate of a novel class of antimycobacterial agents, the diarylquinolines, which specifically inhibit mycobacterial ATP synthase and displays high activity against both drug-susceptible and multidrug-resistant strains of Mycobacterium tuberculosis. This article covers both synthesis pathways as well as qualitative and quantitative analyses of the structureactivity relationships of the diarylquinoline series on Mycobacterium smegmatis activity. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Future Medicinal Chemistry. - London, 2009, currens
|
|
|
Publication
|
|
|
|
London
:
Future Science Ltd
,
2011
|
|
|
ISSN
|
|
|
|
1756-8927
1756-8919
|
|
|
DOI
|
|
|
|
10.4155/FMC.11.79
|
|
|
Volume/pages
|
|
|
|
3
:11
(2011)
, p. 1345-1360
|
|
|
ISI
|
|
|
|
000294544900009
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|